Brief: Oncorus Presents Preclinical Data Supporting ONCR-719, An Armed HSV-1 Vector Engineered To Use The Epidermal Growth Factor Receptor (EGFR/EGFRvIII) For Viral Entry In Glioblastoma

Oncorus

18/11/2022 13:11

Nov 18 (Reuters) - Oncorus Inc  ONCR.O :
    * ONCORUS PRESENTS PRECLINICAL DATA SUPPORTING ONCR-719, AN
ARMED
HSV-1 VECTOR ENGINEERED TO USE THE EPIDERMAL GROWTH FACTOR
RECEPTOR (EGFR/EGFRVIII) FOR VIRAL ENTRY IN GLIOBLASTOMA, AT THE
2022 SOCIETY FOR NEURO-ONCOLOGY ANNUAL MEETING

Source text for Eikon:  ID:nGNX3kMFfV 
Further company coverage:  ONCR.O